PW MEDTECH (01358.HK) -0.020 (-1.695%) announced that its subsidiary, Sichuan Ruijian Medical, has proposed a share buyback. The repurchase is expected to involve no more than 26.1904 million shares, representing approximately 8.53% of its total share capital. Upon completion, the Company's shareholding in Sichuan Ruijian Medical will increase from the current 48.49% to 53.01%. (de/d)(HK stocks quote is delayed for at least 15 mins.)
AASTOCKS Financial News